Human immunoglobulin heavy chain variable region family 3 (VH3)

The Human immunoglobulin VH3 family Fab regions are a specific class of antibody variable domains encoded by the IGHV3 gene family, which represents the most prevalent VH family in the human germline [1][4]. These regions are structurally unique due to their ability to bind certain bacterial superantigens, most notably Staphylococcal Protein A (SpA), through conserved framework residues rather than the traditional antigen-binding site [1][2]. This interaction allows for the broad stimulation or depletion of B-cells expressing VH3-encoded receptors. In clinical medicine, the VH3 family is a critical focus in oncology and rheumatology; for example, the expression of the IGHV3-21 gene is a well-established biomarker for poor prognosis in chronic lymphocytic leukemia (CLL) [3]. Additionally, VH3-encoded autoantibodies are frequently implicated in the pathogenesis of rheumatoid arthritis and other systemic autoimmune diseases [4]. Therapeutic approaches targeting the VH3 framework are being explored to selectively eliminate pathogenic B-cell clones or to modulate immune responses in the context of malignancy and autoimmunity [2][4].

Other names

IGHV3 familyVH3 domainHuman VH3 FabImmunoglobulin VH3

Binding to the VH3 framework regions to cross-link B-cell receptors, leading to activation-induced cell death or anergy.